ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Cell Therapeutics


Include trials that are no longer recruiting patients.

9 studies were found.
1.No longer recruitingArsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
Conditions: refractory plasma cell neoplasm; stage II multiple myeloma; stage III multiple myeloma
2.No longer recruitingArsenic Trioxide in Treating Patients With Multiple Myeloma
Conditions: stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
3.No longer recruitingArsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Conditions: atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
4.No longer recruitingCT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy
Conditions: stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
5.RecruitingPhase 3 BBR 2778 for Relapsed, Aggressive Non-Hodgkin’s Lymphoma (NHL)
Condition: Lymphoma, Non-Hodgkin
6.No longer recruitingPhase II CT-2103/Carboplatin in Ovarian Cancer
Condition: Ovarian Neoplasm
7.No longer recruitingPolyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
8.No longer recruitingPolyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
9.No longer recruitingPolyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act